The clinical outcome in radiooncological treatment of malignant tumors such
as glioblastomas and non-small-cell lung cancer is disappointing. In order
to obtain a better local tumor control and survival rates, dose escalation
seems to be an appropriate way. Especially in those anatomical sites where
radiosensitive tissues surround the tumor a further increase of the total
radiation dose with conventional radiotherapy is critical. In numerous stud
ies 3-D treatment planning and its clinical realization as conformal radiot
herapy demonstrated an improvement in dose distribution for the target volu
me as well as the surrounding radiosensitive tissues compared with 2-D conv
entional treatment planning. The high-dose region was very well conformed t
o the tumor. Outside the tumor the radiation dose decreased steeply. For pr
ostate cancer it has been shown that an increase of the total dose is toler
able. The number of normal tissue complications remained low. We expect tha
t 3-D treatment planning and conformal radiotherapy may substantially impro
ve the therapeutic ratio. There is no doubt that oncology in general, and e
specially radiooncology, may profit from this new technology in the near fu
ture. Continued clinical research, however, is necessary to take full advan
tage of this promising method.